Cryptococcus: Difference between revisions
From IDWiki
Cryptococcus
(→) |
(→: links) |
||
Line 1: | Line 1: | ||
== Management == |
== Management == |
||
=== Patients with HIV === |
=== Patients with HIV === |
||
==== CNS disease ==== |
==== CNS disease ==== |
||
⚫ | |||
⚫ | |||
** IV formulations may be used in severe cases and in those without oral intake where the preparation is available) for at least 2 weeks |
** IV formulations may be used in severe cases and in those without oral intake where the preparation is available) for at least 2 weeks |
||
* Consolidation: fluconazole (400 mg [6 mg/kg] per day orally) for a minimum of 8 weeks |
* Consolidation: [[Is treated by::fluconazole]] (400 mg [6 mg/kg] per day orally) for a minimum of 8 weeks |
||
* Maintenance: |
* Maintenance: |
||
** Fluconazole (200 mg per day orally) or |
** [[Is treated by::Fluconazole]] (200 mg per day orally) or [[Is treated by::itraconazole]] (200 mg twice per day orally; drug-level monitoring strongly advised) |
||
** Start HAART 2–10 weeks after starting antifungals |
** Start HAART 2–10 weeks after starting antifungals |
||
** Consider stopping antifungals once CD4 >= 100 for 3 months |
** Consider stopping antifungals once CD4 >= 100 for 3 months |
||
==== Fungemia ==== |
==== Fungemia ==== |
||
* First, rule out meningitis with an LP |
* First, rule out meningitis with an LP |
||
* If no meningitis, can treat with fluconazole 400 mg po daily until immune reconstitution |
* If no meningitis, can treat with fluconazole 400 mg po daily until immune reconstitution |
||
=== Organ transplant patients === |
=== Organ transplant patients === |
||
* Always consider decreasing immunosuppression if able to |
* Always consider decreasing immunosuppression if able to |
||
==== CNS, severe, or disseminated disease ==== |
==== CNS, severe, or disseminated disease ==== |
||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
==== Mild-to-moderate non-CNS disease ==== |
==== Mild-to-moderate non-CNS disease ==== |
||
* Includes mild-to-moderate pulmonary disease |
* Includes mild-to-moderate pulmonary disease |
||
* Fluconazole (400 mg [6 mg/kg] per day) for 6–12 months |
* [[Fluconazole]] (400 mg [6 mg/kg] per day) for 6–12 months |
||
=== Patients without HIV or organ transplants === |
=== Patients without HIV or organ transplants === |
||
⚫ | |||
⚫ | |||
** If neurological complications or positive CSF cultures after 2 weeks of treatment, consider extending to 6 weeks total |
** If neurological complications or positive CSF cultures after 2 weeks of treatment, consider extending to 6 weeks total |
||
** If not including flucytosine, then extend induction by 2 weeks |
** If not including flucytosine, then extend induction by 2 weeks |
||
** |
** If there is [[amphotericin B deoxycholate]] toxicity, [[Is treated by::liposomal amphotericin B]] may be substituted in the second 2 weeks |
||
* Consolidation: fluconazole (400 mg per day) for 8 weeks |
* Consolidation: [[Is treated by::fluconazole]] (400 mg per day) for 8 weeks |
||
* Maintenance: fluconazole (200 mg [3 mg/kg] per day orally) for 6–12 months |
* Maintenance: [[Is treated by::fluconazole]] (200 mg [3 mg/kg] per day orally) for 6–12 months |
||
=== Pregnant patients === |
=== Pregnant patients === |
||
* See review at [https://doi.org/10.1093/mmy/myz084] |
* See review at [https://doi.org/10.1093/mmy/myz084] |
||
* In short, amphotericin monotherapy is recommended, since fluconazole is teratogenic |
* In short, [[Is treated by::amphotericin B]] monotherapy is recommended, since [[fluconazole]] is teratogenic |
||
== Further Reading == |
== Further Reading == |
Revision as of 11:25, 21 November 2019
Management
Patients with HIV
CNS disease
- Induction (first 2+ weeks): liposomal amphotericin B (3-4 mg/kg IV daily) plus flucytosine (100 mg/kg per day orally in 4 divided doses)
- IV formulations may be used in severe cases and in those without oral intake where the preparation is available) for at least 2 weeks
- Consolidation: fluconazole (400 mg [6 mg/kg] per day orally) for a minimum of 8 weeks
- Maintenance:
- Fluconazole (200 mg per day orally) or itraconazole (200 mg twice per day orally; drug-level monitoring strongly advised)
- Start HAART 2–10 weeks after starting antifungals
- Consider stopping antifungals once CD4 >= 100 for 3 months
Fungemia
- First, rule out meningitis with an LP
- If no meningitis, can treat with fluconazole 400 mg po daily until immune reconstitution
Organ transplant patients
- Always consider decreasing immunosuppression if able to
CNS, severe, or disseminated disease
- Induction (first 2+ weeks): liposomal amphotericin B (3–4 mg/kg per day IV) plus flucytosine (100 mg/kg per day in 4 divided doses)
- If not including flucytosine, then extend induction to 4-6 weeks
- Consolidation: fluconazole (400–800 mg [6–12 mg/kg] per day orally) for 8 weeks, then by fluconazole (200–400 mg per day orally) for 6–12 months (B-II)
Mild-to-moderate non-CNS disease
- Includes mild-to-moderate pulmonary disease
- Fluconazole (400 mg [6 mg/kg] per day) for 6–12 months
Patients without HIV or organ transplants
- Induction (first 4+ weeks): amphotericin B deoxycholate (0.7–1.0 mg/kg per day IV) plus flucytosine (100 mg/kg per day orally in 4 divided doses)
- If neurological complications or positive CSF cultures after 2 weeks of treatment, consider extending to 6 weeks total
- If not including flucytosine, then extend induction by 2 weeks
- If there is amphotericin B deoxycholate toxicity, liposomal amphotericin B may be substituted in the second 2 weeks
- Consolidation: fluconazole (400 mg per day) for 8 weeks
- Maintenance: fluconazole (200 mg [3 mg/kg] per day orally) for 6–12 months
Pregnant patients
- See review at [1]
- In short, amphotericin B monotherapy is recommended, since fluconazole is teratogenic
Further Reading
- IDSA Guidelines 2010